Literature DB >> 18377771

Changing paradigms in the immunological science of allergy: 2008.

Edward J Goetzl1.   

Abstract

Our evolving knowledge of the universe of immune cytokines has permitted more precise definition of the extensive involvement of many cell-derived protein factors in the mediation of allergic diseases and asthma. Several newly recognized cytokines, which are derived from epithelial cells of the respiratory system, skin, and gastrointestinal tract or intraepithelial T cells in the context of interactions with nonimmune parenchymal cells, have potent stimulatory or inhibitory effects on the differentiation and/or activities of T helper (Th) 2-type CD4 T cells. Their properties and effects are reviewed from the perspective of novel targets for antiallergic therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18377771     DOI: 10.1007/s11882-008-0006-x

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  16 in total

Review 1.  Thymic stromal lymphopoietin in normal and pathogenic T cell development and function.

Authors:  Steven F Ziegler; Yong-Jun Liu
Journal:  Nat Immunol       Date:  2006-07       Impact factor: 25.606

2.  Interleukin-18 and its three gene polymorphisms relating to allergic rhinitis.

Authors:  Sarka Sebelova; Lydie Izakovicova-Holla; Andrea Stejskalova; Marcel Schüller; Vladimir Znojil; Anna Vasku
Journal:  J Hum Genet       Date:  2007-01-25       Impact factor: 3.172

3.  IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.

Authors:  Jochen Schmitz; Alexander Owyang; Elizabeth Oldham; Yaoli Song; Erin Murphy; Terril K McClanahan; Gerard Zurawski; Mehrdad Moshrefi; Jinzhong Qin; Xiaoxia Li; Daniel M Gorman; J Fernando Bazan; Robert A Kastelein
Journal:  Immunity       Date:  2005-11       Impact factor: 31.745

4.  An essential role for IL-18 in CD8 T cell-mediated suppression of IgE responses.

Authors:  Maria Salagianni; Kok Loon Wong; Wong Kok Loon; Matthew J Thomas; Alistair Noble; David M Kemeny
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

5.  Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets.

Authors:  Georgina Xanthou; Themis Alissafi; Maria Semitekolou; Davina C M Simoes; Erasmia Economidou; Mina Gaga; Bart N Lambrecht; Clare M Lloyd; Vily Panoutsakopoulou
Journal:  Nat Med       Date:  2007-04-15       Impact factor: 53.440

Review 6.  The immunology of Eta-1/osteopontin.

Authors:  G F Weber; H Cantor
Journal:  Cytokine Growth Factor Rev       Date:  1996-10       Impact factor: 7.638

Review 7.  Roles of IL-18 in basophils and mast cells.

Authors:  Tomohiro Yoshimoto; Kenji Nakanishi
Journal:  Allergol Int       Date:  2006-06       Impact factor: 5.836

8.  Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP.

Authors:  Vassili Soumelis; Pedro A Reche; Holger Kanzler; Wei Yuan; Gina Edward; Bernhart Homey; Michel Gilliet; Steve Ho; Svetlana Antonenko; Annti Lauerma; Kathleen Smith; Daniel Gorman; Sandra Zurawski; Jon Abrams; Satish Menon; Terri McClanahan; Rene de Waal-Malefyt Rd; Fernando Bazan; Robert A Kastelein; Yong-Jun Liu
Journal:  Nat Immunol       Date:  2002-06-10       Impact factor: 25.606

9.  TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells.

Authors:  Atsushi Kato; Silvio Favoreto; Pedro C Avila; Robert P Schleimer
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

10.  Cutting edge: direct action of thymic stromal lymphopoietin on activated human CD4+ T cells.

Authors:  Irina Rochman; Norihiko Watanabe; Kazuhiko Arima; Yong-Jun Liu; Warren J Leonard
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

View more
  1 in total

Review 1.  A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya).

Authors:  Jerold Chun; Volker Brinkmann
Journal:  Discov Med       Date:  2011-09       Impact factor: 2.970

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.